SCHEMBL23587146

SCHEMBL23587146

C/C=C(/CCc1ccccn1)N=C(C)C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.44
▸ HRH1 P35367 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ CYP1A2 P05177 6/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TSHR P16473 2/20 0.39
▸ APP P05067 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22872467 0.78 HRH1 (0.50) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL21872596 0.73 HRH1 (0.52) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL2722250 0.73 ALDH1A1 (0.57) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL1760708 0.69 HRH1 (0.52) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL1760709 0.69 HRH1 (0.52) HRH3HRH1ALDH1A1LMNATAAR1
Lithium Ion SCHEMBL28463950 0.69 CYP1A2 (0.56) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL18901920 0.69 HRH3 (0.47) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL29485678 0.69 HRH1 (0.73) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL230753 0.69 HRH1 (0.73) HRH3HRH1ALDH1A1LMNATAAR1
SCHEMBL27877150 0.69 HRH3 (0.50) HRH3HRH1ALDH1A1LMNATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3842436-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE DERIVATIVES FOR USE IN THE TREATMENT OF SCHIZOPHRENIA SK Biopharmaceuticals Co., Ltd. (KR) 2021-06-30 — — EP disclosed
Send feedback